Real World Effectiveness of Golimumab Therapy in Ulcerative Colitis Regardless of Prior TNF Exposure.

Journal of the Canadian Association of Gastroenterology(2018)

引用 9|浏览8
暂无评分
摘要
Overall, the persistence rate of golimumab observed in the current real-world study is similar to that described in previous single-centre UC cohorts and consistent with that seen in controlled clinical trials.
更多
查看译文
关键词
Biologics,Compliance/adherence,Inflammatory bowel disease,Ulcerative colitis
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要